Staar Surgical, Howard Hughes Holdings, and More Stocks See Action From Activist Investors

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Broadwood Capital bought more shares of Staar Surgical, a maker of implantable eye lenses. Pershing Square raised its stake in real estate developer Howard...

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Oct. 5 through Oct. 11, 2023. Source: VerityDataBroadwood Capital lifted its position in the maker of implantable lenses for the eye to 9,469,723 shares.

In September, Appian secured a $500 million judgment preservation insurance policy, tied to an earlier trade-secret case against Pegasystems heard in Virginia state court. The court found in favor of Appian and awarded the firm $2.036 billion in damages in May 2022, a ruling upheld later that same year. Pegasystems has appealed the decision.

Appian’s insurance policy will ensure that if the final judgment falls below $500 million after all appeals are exhausted, Appian will receive a payment equal to the difference between the award and $500 million. William Blair analyst Jake Roberge reiterated an Outperform rating on Appian stock in early September, when the company announced the insurance policy. Appian “continues to execute well, as its market-leading low-code platform delivers,” wrote Roberge in a research report.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 3. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

日本 最新ニュース, 日本 見出し